» Articles » PMID: 26966517

Effects of Preoperative Proton Pump Inhibitor Administration on Bleeding After Gastric Endoscopic Submucosal Dissection: A Systematic Review and Meta-analysis

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2016 Mar 12
PMID 26966517
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: The efficacy of using proton pump inhibitors (PPIs) prior to gastric endoscopic submucosal dissection (ESD) to reduce gastric bleeding remains controversial. This study aimed to systematically review the literature to evaluate the efficacy of preoperative PPI use to reduce post-ESD bleeding.

Methods: PubMed, the Cochrane library, and the Igaku-Chuo-Zasshi database were searched to identify randomized trials eligible for inclusion in the systematic review. Data from four studies (406 patients) were combined to calculate a pooled risk difference (RD) for developing post-ESD bleeding.

Results: Compared with patients who received no premedication, the pooled RD for post-ESD bleeding in patients who received preoperavive PPI was -0.027 (95% confidence interval: -0.070-0.017, p = 0.228), without significant heterogeneity. Preoperavive PPI use significantly increased gastric pH (weighted mean difference: 1.289, 95% CI: 0.227-2.352, p = 0.0174).

Conclusions: This systematic review and meta-analysis showed that premedication with PPI had no advantage for the prevention of post-ESD bleeding, despite increasing gastric pH.

Citing Articles

Endoscopic Resection of Early Gastric Cancer and Pre-Malignant Gastric Lesions.

Vasconcelos A, Dinis-Ribeiro M, Libanio D Cancers (Basel). 2023; 15(12).

PMID: 37370695 PMC: 10296667. DOI: 10.3390/cancers15123084.


Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold.

Young E, Philpott H, Singh R World J Gastroenterol. 2021; 27(31):5126-5151.

PMID: 34497440 PMC: 8384753. DOI: 10.3748/wjg.v27.i31.5126.


Clinical practice guideline for endoscopic resection of early gastrointestinal cancer.

Park C, Yang D, Kim J, Kim J, Kim J, Min Y Intest Res. 2020; 19(2):127-157.

PMID: 33045799 PMC: 8100377. DOI: 10.5217/ir.2020.00020.


Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis.

Nishizawa T, Mori K, Yoshida S, Ebinuma H, Toyoshima O, Suzuki H J Clin Med. 2020; 9(9).

PMID: 32825721 PMC: 7565487. DOI: 10.3390/jcm9092705.


Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer.

Park C, Yang D, Kim J, Kim J, Kim J, Min Y Clin Endosc. 2020; 53(2):142-166.

PMID: 32252507 PMC: 7137564. DOI: 10.5946/ce.2020.032.


References
1.
Hikichi T, Sato M, Watanabe K, Nakamura J, Takagi T, Suzuki R . Oral rabeprazole administration on a procedure day suppresses bleeding after endoscopic submucosal dissection for gastric neoplasms. Fukushima J Med Sci. 2014; 60(1):68-74. DOI: 10.5387/fms.2013-17. View

2.
Baeg M, Choi M, Moon S, Lim C, Kim J, Cho Y . Preprocedural rabeprazole treatment before endoscopic submucosal dissection for gastric neoplasms. Dig Dis Sci. 2014; 59(9):2243-8. DOI: 10.1007/s10620-014-3117-3. View

3.
Nishizawa T, Suzuki H, Kanai T, Yahagi N . Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis. J Clin Biochem Nutr. 2015; 56(2):85-90. PMC: 4345174. DOI: 10.3164/jcbn.14-101. View

4.
Takizawa K, Oda I, Gotoda T, Yokoi C, Matsuda T, Saito Y . Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection--an analysis of risk factors. Endoscopy. 2008; 40(3):179-83. DOI: 10.1055/s-2007-995530. View

5.
Ozawa T, Yoshikawa N, Tomita T, Akita Y, Mitamura K . The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer. J Gastroenterol. 2003; 38(9):844-8. DOI: 10.1007/s00535-003-1159-y. View